Verrica Pharmaceuticals Inc (VRCA)
1.00
+0.01
(+1.01%)
USD |
NASDAQ |
Nov 22, 16:00
1.00
0.00 (0.00%)
After-Hours: 20:00
Verrica Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 89.53% |
| March 31, 2024 | 70.26% |
| December 31, 2023 | 86.32% |
| September 30, 2023 | 90.74% |
| June 30, 2023 | 25.27% |
| Date | Value |
|---|---|
| March 31, 2023 | -83.78% |
| December 31, 2022 | 8.82% |
| September 30, 2022 | 98.00% |
| June 30, 2022 | -2.34% |
| March 31, 2022 | 35.50% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-83.78%
Minimum
Mar 2023
98.00%
Maximum
Sep 2022
41.83%
Average
52.88%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 74.73% |
| Elite Pharmaceuticals Inc | 43.42% |
| Eagle Pharmaceuticals Inc | -- |
| TELA Bio Inc | 67.83% |
| Terns Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.62K% |
| Return on Assets | -128.8% |
| Return on Invested Capital | -184.4% |
| Return on Net Operating Assets | -746.9% |